Exela Pharma Sciences

Cadence: Patent Settlement With Sandoz Increases Confidence That Ofirmev Will Have Exclusivity Through December 6, 2020
Seeking Alpha
Fri, 01/31/14 - 08:45 am
Cadence Pharmaceuticals
Sandoz
Ofirmev
Exela Pharma Sciences
Cadence: Best Case Outcome On Ofirmev Patent Litigation
Seeking Alpha
Fri, 11/15/13 - 09:55 am
Cadence Pharmaceuticals
Ofirmev
patents
Exela Pharma Sciences